Chinese maker of laundry detergent, fabric softener and household cleaning products under the Blue Moon brand.
Chinese maker of laundry detergent, fabric softener and household cleaning products under the Blue Moon brand.
Sells mass-market home-care products through supermarkets and online platforms, with liquid laundry products the main line and fabric care and hand-washing products added around it. Founder Luo Qiuping controls the company, and sales are mainly in mainland China.
In one line: China's Procter & Gamble for laundry/home care.
Moat: narrow (brand, distribution). Leading, widely trusted household-cleaning brand in China with strong e-commerce distribution.
Headquarters: Guangzhou, China · Founded: 1992 · Employees: 6,514
Size Blue Moon (6993.HK) is a Hong Kong Consumer Staples company (Household/Personal Care) with a market value of $2.07B, the 401st largest of 885 Hong Kong companies the cockpit tracks. Shares closed at HK$2.89 on 18 Nov 2026.
Performance Over six months the shares fell 4.3%, against -1.6% for the median peer and -14.0% for the Hong Kong market (cap-weighted) — 11th highest of 21 in its peer set.
Growth Revenue fell 2.4% over the last twelve months (peer median +5.6%); the operating margin is -2.0% (peer median 10.6%).
Valuation It trades at 103.3× forward earnings against a peer median of 19.5× (most expensive of 21).
Capital Return on invested capital runs 11.3 points below its cost of capital (7.9% WACC).
Next results Next results expected around 30 Mar 2027 (exchange calendar; dates can move).
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|---|
| Revenue | HK$8.25B | HK$8.41B | HK$8.56B | HK$7.32B | HK$7.95B |
| Revenue growth | — | -2% | +17% | -8% | — |
| Gross profit | HK$4.75B | HK$4.88B | HK$5.02B | HK$4.36B | HK$4.41B |
| EBITDA | HK$59.1M | -HK$206M | -HK$740M | HK$351M | HK$1.02B |
| Net income | -HK$86.1M | -HK$329M | -HK$749M | HK$325M | HK$611M |
| Free cash flow | -HK$198M | -HK$543M | -HK$1.03B | HK$657M | HK$266M |
| Capital expenditure | HK$348M | HK$191M | HK$150M | HK$92.6M | HK$289M |
| Total debt | n/a | HK$84.9M | HK$99.7M | HK$159M | HK$200M |
The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.
| Company | Market cap | 6M return | Revenue growth | Op. margin | Forward P/E | Req g |
|---|---|---|---|---|---|---|
| Blue Moon 6993.HK | $2.07B | -4% | -2% | -2% | 103.3× | n/a |
| Procter & Gamble PG | $395B | +20% | +4% | 24% | 24.1× | 0.5% |
| Unilever ULVR.L | $139B | +15% | -20% | 20% | 18.2× | 8.1% |
Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.
| Measure | 6993.HK | Peer median | Rank in peer set |
|---|---|---|---|
| 1-month return | +11.6% | +0.9% | 2nd highest of 21 |
| 6-month return | -4.3% | -1.6% | 11th highest of 21 |
| Distance from 52-week high | -27.3% | -24.8% | 9th lowest of 21 |
| Revenue growth (TTM) | -2.4% | +5.6% | 5th lowest of 21 |
| Operating margin | -2.0% | 10.6% | lowest of 21 |
| Forward P/E | 103.3× | 19.5× | most expensive of 21 |
| ROIC minus cost of capital | -11.3 pp | +5.4 pp | lowest of 20 |
| Net debt / EBITDA | -46.7× | -1.1× | least indebted of 15 |
| Company | Market | Market cap | 6M return | Revenue growth | Op. margin | Forward P/E | Req g | Delivered g |
|---|---|---|---|---|---|---|---|---|
| Blue Moon 6993.HK | Hong Kong | $2.07B | -4% | -2% | -2% | 103.3× | n/a | n/a |
| Kolmar Korea 161890.KS | South Korea | $2.05B | +14% | +16% | 10% | 14.3× | -1.6% | +15.5% |
| Pola Orbis 4927.T | Japan | $2.04B | +15% | +1% | 11% | 30.6× | -2.0% | -0.7% |
| KOSE 4922.T | Japan | $2.16B | +16% | +4% | 5% | 29.9× | n/a | n/a |
| Softcare 2698.HK | Hong Kong | $2.20B | +5% | +25% | 25% | 14.4× | 9.1% | +20.9% |
| Emami EMAMILTD.NS | India | $1.94B | -5% | +13% | 20% | 23.4× | 21.5% | +5.6% |
| Energizer ENR | United States | $1.94B | +71% | 0% | 17% | 9.1× | -5.1% | -0.5% |
| Procter & Gamble Hygiene & Health Care PGHH.NS | India | $2.37B | -30% | -2% | 24% | 27.0× | 21.2% | +7.4% |
| Pigeon 7956.T | Japan | $1.76B | +26% | +8% | 13% | 27.9× | -2.4% | +1.9% |
| Giant Biogene 2367.HK | Hong Kong | $2.47B | -32% | -10% | 32% | 8.6× | -10.7% | +34.9% |
| Cosmax 192820.KS | South Korea | $2.51B | +53% | +25% | 8% | 18.8× | n/a | n/a |
| Winner Medical 300888.SZ | China | $2.53B | -6% | +4% | 11% | 19.9× | -5.2% | -2.6% |
| Gillette India GILLETTE.NS | India | $2.53B | -5% | +8% | 28% | 37.1× | 14.9% | +13.0% |
| Yunnan Botanee Bio-Technology 300957.SZ | China | $1.69B | -33% | +7% | 9% | 19.1× | 2.6% | +15.3% |
| Guangdong Marubi Biotechnology 603983.SS | China | $1.62B | +9% | -6% | 2% | 45.5× | n/a | n/a |
| Shanghai Jahwa United 600315.SS | China | $1.61B | -15% | +9% | 2% | 15.4× | 15.3% | -2.1% |
| AMOREPACIFIC 002790.KS | South Korea | $1.61B | +2% | +9% | 9% | 8.5× | -5.7% | -1.3% |
| LG H&h 051900.KS | South Korea | $2.81B | -14% | -3% | 3% | 23.1× | -4.6% | -4.1% |
| Harbin Fuerjia Technology 301371.SZ | China | $1.51B | -39% | +28% | 20% | 21.4× | 7.5% | +3.6% |
| Proya Cosmetics 603605.SS | China | $2.87B | -13% | +2% | 13% | 10.9× | -5.3% | +23.1% |
| Intercos ICOS.MI | Italy | $1.43B | +12% | -5% | 9% | 18.9× | 4.3% | +11.5% |